Redefined clinical spectra of diabetic foot syndrome
The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to predict amputations. This is a retrospective study of type 2 diabetic patients referred with DFS for management at King Abdullah University Hospita...
Saved in:
Published in | Vascular health and risk management Vol. 14; pp. 291 - 298 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
New Zealand
Dove Medical Press Limited
01.01.2018
Dove Medical Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to predict amputations.
This is a retrospective study of type 2 diabetic patients referred with DFS for management at King Abdullah University Hospital (KAUH) between January 2014 and December 2015. Data collection form and diabetic foot (DF) characteristic chart were used to document the following: demographic data, diabetes-related parameters, DF characteristics, surgical interventions and amputations. The predominant clinical presentations of DF problems (ulcer, sepsis or gangrene) were integrated with the clinical criteria for diabetic foot infection (DFI) diagnosis and classification of Infectious Diseases Association of America (IDSA)/International Working Group on Diabetic Foot (IWGDF) to redefine the clinical spectra of DFS. Related risk characteristics and amputation rate at all levels were compared between the three RCS.
In this study, there were 95 (47.0%) septic DFS (SDFS) patients, 65 (32.2%) ulcerative DFS (UDFS) patients and 42 (20.8%) gangrenous DFS (GDFS) patients. Poor glycemic control (HbA1c >7.5%), hypertension, history of the same foot problems, duration of symptoms, revascularizations and ischemic severity were significantly different between the three RCS. UDFS had the highest rate of limb salvage without amputations (70.8%). GDFS had the highest rate for final toe amputations (52.4%) and major amputations (23.8%). Final minor amputation rate was around 20% for both SDFS and GDFS.
Redefining DFS into ulcerative, septic and gangrenous by integration of the predominant clinical presentation and the clinical criteria for DFI diagnosis and classification of IDSA/IWGDF showed significant differences in amputation rate. Therefore, it can be used clinically to categorize patients with DFS to predict amputations and to help in planning their management. Further prospective studies are suggested to validate these results. |
---|---|
AbstractList | Purpose: The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to predict amputations. Patients and methods: This is a retrospective study of type 2 diabetic patients referred with DFS for management at King Abdullah University Hospital (KAUH) between January 2014 and December 2015. Data collection form and diabetic foot (DF) characteristic chart were used to document the following: demographic data, diabetes-related parameters, DF characteristics, surgical interventions and amputations. The predominant clinical presentations of DF problems (ulcer, sepsis or gangrene) were integrated with the clinical criteria for diabetic foot infection (DFI) diagnosis and classification of Infectious Diseases Association of America (IDSA)/International Working Group on Diabetic Foot (IWGDF) to redefine the clinical spectra of DFS. Related risk characteristics and amputation rate at all levels were compared between the three RCS. Results: In this study, there were 95 (47.0%) septic DFS (SDFS) patients, 65 (32.2%) ulcerative DFS (UDFS) patients and 42 (20.8%) gangrenous DFS (GDFS) patients. Poor glycemic control (HbA1c >7.5%), hypertension, history of the same foot problems, duration of symptoms, revascularizations and ischemic severity were significantly different between the three RCS. UDFS had the highest rate of limb salvage without amputations (70.8%). GDFS had the highest rate for final toe amputations (52.4%) and major amputations (23.8%). Final minor amputation rate was around 20% for both SDFS and GDFS. Conclusion: Redefining DFS into ulcerative, septic and gangrenous by integration of the predominant clinical presentation and the clinical criteria for DFI diagnosis and classification of IDSA/IWGDF showed significant differences in amputation rate. Therefore, it can be used clinically to categorize patients with DFS to predict amputations and to help in planning their management. Further prospective studies are suggested to validate these results. Keywords: diabetes mellitus, classification, diabetic foot syndrome, amputations Nawaf J Shatnawi,1 Nabil A Al-Zoubi,1 Hasan Hawamdeh,2 Yousef S Khader,3 Abd El-Karim Omari,1 Muhammad R Khammash1 1Department of Surgery, Jordan University of Science and Technology, Irbid, Jordan; 2Department of Basic Medical Science, Faculty of Medicine, Hashemite University, Zarqa, Jordan; 3Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science and Technology, Irbid, Jordan Purpose: The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to predict amputations. Patients and methods: This is a retrospective study of type 2 diabetic patients referred with DFS for management at King Abdullah University Hospital (KAUH) between January 2014 and December 2015. Data collection form and diabetic foot (DF) characteristic chart were used to document the following: demographic data, diabetes-related parameters, DF characteristics, surgical interventions and amputations. The predominant clinical presentations of DF problems (ulcer, sepsis or gangrene) were integrated with the clinical criteria for diabetic foot infection (DFI) diagnosis and classification of Infectious Diseases Association of America (IDSA)/International Working Group on Diabetic Foot (IWGDF) to redefine the clinical spectra of DFS. Related risk characteristics and amputation rate at all levels were compared between the three RCS. Results: In this study, there were 95 (47.0%) septic DFS (SDFS) patients, 65 (32.2%) ulcerative DFS (UDFS) patients and 42 (20.8%) gangrenous DFS (GDFS) patients. Poor glycemic control (HbA1c >7.5%), hypertension, history of the same foot problems, duration of symptoms, revascularizations and ischemic severity were significantly different between the three RCS. UDFS had the highest rate of limb salvage without amputations (70.8%). GDFS had the highest rate for final toe amputations (52.4%) and major amputations (23.8%). Final minor amputation rate was around 20% for both SDFS and GDFS. Conclusion: Redefining DFS into ulcerative, septic and gangrenous by integration of the predominant clinical presentation and the clinical criteria for DFI diagnosis and classification of IDSA/IWGDF showed significant differences in amputation rate. Therefore, it can be used clinically to categorize patients with DFS to predict amputations and to help in planning their management. Further prospective studies are suggested to validate these results. Keywords: diabetes mellitus, classification, diabetic foot syndrome, amputations The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to predict amputations. This is a retrospective study of type 2 diabetic patients referred with DFS for management at King Abdullah University Hospital (KAUH) between January 2014 and December 2015. Data collection form and diabetic foot (DF) characteristic chart were used to document the following: demographic data, diabetes-related parameters, DF characteristics, surgical interventions and amputations. The predominant clinical presentations of DF problems (ulcer, sepsis or gangrene) were integrated with the clinical criteria for diabetic foot infection (DFI) diagnosis and classification of Infectious Diseases Association of America (IDSA)/International Working Group on Diabetic Foot (IWGDF) to redefine the clinical spectra of DFS. Related risk characteristics and amputation rate at all levels were compared between the three RCS. In this study, there were 95 (47.0%) septic DFS (SDFS) patients, 65 (32.2%) ulcerative DFS (UDFS) patients and 42 (20.8%) gangrenous DFS (GDFS) patients. Poor glycemic control (HbA1c >7.5%), hypertension, history of the same foot problems, duration of symptoms, revascularizations and ischemic severity were significantly different between the three RCS. UDFS had the highest rate of limb salvage without amputations (70.8%). GDFS had the highest rate for final toe amputations (52.4%) and major amputations (23.8%). Final minor amputation rate was around 20% for both SDFS and GDFS. Redefining DFS into ulcerative, septic and gangrenous by integration of the predominant clinical presentation and the clinical criteria for DFI diagnosis and classification of IDSA/IWGDF showed significant differences in amputation rate. Therefore, it can be used clinically to categorize patients with DFS to predict amputations and to help in planning their management. Further prospective studies are suggested to validate these results. PURPOSEThe aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to predict amputations. PATIENTS AND METHODSThis is a retrospective study of type 2 diabetic patients referred with DFS for management at King Abdullah University Hospital (KAUH) between January 2014 and December 2015. Data collection form and diabetic foot (DF) characteristic chart were used to document the following: demographic data, diabetes-related parameters, DF characteristics, surgical interventions and amputations. The predominant clinical presentations of DF problems (ulcer, sepsis or gangrene) were integrated with the clinical criteria for diabetic foot infection (DFI) diagnosis and classification of Infectious Diseases Association of America (IDSA)/International Working Group on Diabetic Foot (IWGDF) to redefine the clinical spectra of DFS. Related risk characteristics and amputation rate at all levels were compared between the three RCS. RESULTSIn this study, there were 95 (47.0%) septic DFS (SDFS) patients, 65 (32.2%) ulcerative DFS (UDFS) patients and 42 (20.8%) gangrenous DFS (GDFS) patients. Poor glycemic control (HbA1c >7.5%), hypertension, history of the same foot problems, duration of symptoms, revascularizations and ischemic severity were significantly different between the three RCS. UDFS had the highest rate of limb salvage without amputations (70.8%). GDFS had the highest rate for final toe amputations (52.4%) and major amputations (23.8%). Final minor amputation rate was around 20% for both SDFS and GDFS. CONCLUSIONRedefining DFS into ulcerative, septic and gangrenous by integration of the predominant clinical presentation and the clinical criteria for DFI diagnosis and classification of IDSA/IWGDF showed significant differences in amputation rate. Therefore, it can be used clinically to categorize patients with DFS to predict amputations and to help in planning their management. Further prospective studies are suggested to validate these results. |
Audience | Academic |
Author | Shatnawi, Nawaf J Khader, Yousef S Khammash, Muhammad R Hawamdeh, Hasan Omari, Abd El-Karim Al-Zoubi, Nabil A |
AuthorAffiliation | 3 Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science and Technology, Irbid, Jordan 1 Department of Surgery, Jordan University of Science and Technology, Irbid, Jordan, nshatnawi@yahoo.com 2 Department of Basic Medical Science, Faculty of Medicine, Hashemite University, Zarqa, Jordan |
AuthorAffiliation_xml | – name: 3 Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science and Technology, Irbid, Jordan – name: 1 Department of Surgery, Jordan University of Science and Technology, Irbid, Jordan, nshatnawi@yahoo.com – name: 2 Department of Basic Medical Science, Faculty of Medicine, Hashemite University, Zarqa, Jordan |
Author_xml | – sequence: 1 givenname: Nawaf J surname: Shatnawi fullname: Shatnawi, Nawaf J email: nshatnawi@yahoo.com organization: Department of Surgery, Jordan University of Science and Technology, Irbid, Jordan, nshatnawi@yahoo.com – sequence: 2 givenname: Nabil A surname: Al-Zoubi fullname: Al-Zoubi, Nabil A email: nshatnawi@yahoo.com organization: Department of Surgery, Jordan University of Science and Technology, Irbid, Jordan, nshatnawi@yahoo.com – sequence: 3 givenname: Hasan surname: Hawamdeh fullname: Hawamdeh, Hasan organization: Department of Basic Medical Science, Faculty of Medicine, Hashemite University, Zarqa, Jordan – sequence: 4 givenname: Yousef S surname: Khader fullname: Khader, Yousef S organization: Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science and Technology, Irbid, Jordan – sequence: 5 givenname: Abd El-Karim surname: Omari fullname: Omari, Abd El-Karim email: nshatnawi@yahoo.com organization: Department of Surgery, Jordan University of Science and Technology, Irbid, Jordan, nshatnawi@yahoo.com – sequence: 6 givenname: Muhammad R surname: Khammash fullname: Khammash, Muhammad R email: nshatnawi@yahoo.com organization: Department of Surgery, Jordan University of Science and Technology, Irbid, Jordan, nshatnawi@yahoo.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30425505$$D View this record in MEDLINE/PubMed |
BookMark | eNptktuLEzEUxoOsuBd981kGBPHB1lxnJi_Csqi7sCKsl9dwkpy0WaZJnUyF_e9NbV1akDwknPzOx3eS75ycpJyQkJeMzjmT3fuf13df5t9YqxXlT8gZY10_41T2JwfnU3Jeyj2lqu0pe0ZOBZVcKarOiLxDjyEm9I0bYooOhqas0U0jNDk0PoLFKbom5Dw15SH5Ma_wOXkaYCj4Yr9fkB-fPn6_up7dfv18c3V5O3NK9tMsAEgvvHTY606zFgMH4KxVOgjbeYqcOQm2U4Gi9sJaH7rWWac47VA4Ly7IzU7XZ7g36zGuYHwwGaL5W8jjwsBY3Q1oOoUgqRfIJcjearAesMfqnlYDwlatDzut9cau0DtMdcThSPT4JsWlWeTfpuWUad1Wgbd7gTH_2mCZzCoWh8MACfOmGM6EkIJpxSv6eocuoFqLKeSq6La4uVQ9V7RXSldq_h-qLo-r6Oonh1jrRw1vDhqWCMO0LHnYTDGncgy-24FuzKWMGB7HZNRsQ2O2oTH70FT81eHTPML_UiL-AJCDvlU |
CitedBy_id | crossref_primary_10_1186_s13047_020_00405_z crossref_primary_10_1097_WON_0000000000000664 crossref_primary_10_7861_clinmed_2019_0392 crossref_primary_10_1021_acsomega_3c06354 crossref_primary_10_1111_ijcp_14892 crossref_primary_10_1111_nep_13596 crossref_primary_10_1177_15347346221109057 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2018 Dove Medical Press Limited 2018 Shatnawi et al. This work is published and licensed by Dove Medical Press Limited 2018 |
Copyright_xml | – notice: COPYRIGHT 2018 Dove Medical Press Limited – notice: 2018 Shatnawi et al. This work is published and licensed by Dove Medical Press Limited 2018 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.2147/VHRM.S169502 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1178-2048 |
EndPage | 298 |
ExternalDocumentID | oai_doaj_org_article_75ea40d3e24a48b9abdae8eabe0d4c3b A582508559 10_2147_VHRM_S169502 30425505 |
Genre | Journal Article Comparative Study |
GroupedDBID | --- 04C 0YH 123 29Q 2WC 53G 5VS 6PF 7RV 7X7 8AO 8FI 8FJ 8G5 AAWTL ABUWG ACGFO ADBBV ADRAZ AFKRA AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AQUVI AZQEC BAWUL BCNDV BENPR BKEYQ BMSDO BPHCQ BVXVI CCPQU CGR CS3 CUY CVF DIK DU5 DWQXO E3Z EBD EBS ECM EIF EIHBH EJD F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HMCUK HYE IAO IHR IHW INH INR IPNFZ ITC KQ8 M0T M2O M48 M~E NAPCQ NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC RIG RNS RPM TR2 UKHRP VDV AAYXX CITATION TDBHL 7X8 5PM |
ID | FETCH-LOGICAL-c548t-faa4d3d4ce897916ef2aa21659f3b7d0e21c4ab75f0e9d3bbdf76cbc5207e3cd3 |
IEDL.DBID | RPM |
ISSN | 1178-2048 1176-6344 |
IngestDate | Tue Oct 22 15:16:38 EDT 2024 Tue Sep 17 21:26:17 EDT 2024 Fri Oct 25 05:16:25 EDT 2024 Thu Feb 22 23:55:19 EST 2024 Sat Dec 16 00:29:51 EST 2023 Tue Aug 20 21:57:20 EDT 2024 Thu Sep 26 16:56:47 EDT 2024 Sat Sep 28 08:22:29 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | diabetic foot syndrome amputations diabetes mellitus classification |
Language | English |
License | The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c548t-faa4d3d4ce897916ef2aa21659f3b7d0e21c4ab75f0e9d3bbdf76cbc5207e3cd3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ORCID | 0000-0002-2328-9383 0000-0002-7830-6857 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201996/ |
PMID | 30425505 |
PQID | 2133431952 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_75ea40d3e24a48b9abdae8eabe0d4c3b pubmedcentral_primary_oai_pubmedcentral_nih_gov_6201996 proquest_miscellaneous_2133431952 gale_infotracmisc_A582508559 gale_infotracacademiconefile_A582508559 gale_healthsolutions_A582508559 crossref_primary_10_2147_VHRM_S169502 pubmed_primary_30425505 |
PublicationCentury | 2000 |
PublicationDate | 2018-01-01 |
PublicationDateYYYYMMDD | 2018-01-01 |
PublicationDate_xml | – month: 01 year: 2018 text: 2018-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New Zealand |
PublicationPlace_xml | – name: New Zealand |
PublicationTitle | Vascular health and risk management |
PublicationTitleAlternate | Vasc Health Risk Manag |
PublicationYear | 2018 |
Publisher | Dove Medical Press Limited Dove Medical Press |
Publisher_xml | – name: Dove Medical Press Limited – name: Dove Medical Press |
SSID | ssj0056801 |
Score | 2.2606704 |
Snippet | The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to... Purpose: The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used... PURPOSEThe aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to... Nawaf J Shatnawi,1 Nabil A Al-Zoubi,1 Hasan Hawamdeh,2 Yousef S Khader,3 Abd El-Karim Omari,1 Muhammad R Khammash1 1Department of Surgery, Jordan University of... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 291 |
SubjectTerms | Amputation Amputations Classification Communicable diseases Data collection Decision Support Techniques Diabetes Mellitus Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - therapy Diabetic foot Diabetic Foot - diagnosis Diabetic Foot - epidemiology Diabetic Foot - therapy Diabetic Foot Syndrome Diabetics Female Foot diseases Gangrene Glycosylated hemoglobin Health aspects Humans Hypertension Infection Jordan - epidemiology Limb Salvage Male Medical research Middle Aged Original Research Predictive Value of Tests Prevalence Prognosis Retrospective Studies Risk Assessment Risk Factors Sepsis - diagnosis Sepsis - epidemiology Sepsis - therapy Therapeutics Wound Infection - diagnosis Wound Infection - epidemiology Wound Infection - therapy |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYQh4pLVQptl0IJUitOKUlsx_ERKtAKiR54iZvlx1hwSdCy_P_OxMlqIw5ceoviUeT5xuN5ZDxm7Ke3XJa8jjnVLuZo8VxuOQjUKx-FtpE6flO1xd96ficuH-TD2lVfVBOW2gMn4E6UBCuKwKESVjROWxcsNGAdFEF47vrdt9BjMJX2YFk3_cXHZaloHYgmlbzTnTwn9_Prq983Za3lkEoZjVHfs__tzrxmmqZlk2t26OIT-zg4kNlpmvg224D2M_twNfwi32HiGgJEfAzZeOox649TLmzWxSzlWp98FrtumY39CnbZ3cX57Z95PlyNkHsMMZZ5tFYEjgBAoxV6eBAra6uyljpyp0IBVemFdUrGAnTgzoWoau-8rAoF3Af-hW22XQvfWKZKrwsZg6wFxiJRN4oLaQG0iKrUTs_YrxEj85w6YBiMHAhLQ1iaAcsZOyMAVzTUt7p_gdI0gzTNe9KcsUOC36RDoCvtM6cSI1kqqcPpHPcUpH-InLfDMQJkhjpZTSj3J5SoN34yfDSK2NAQFZu10L2-IGuco1-lJfL0NYl8xRVlfyiomzE1WQwTtqcj7dNj37a7Rl8Lo8u9_4HTd7aFX2tSLmifbS4Xr3CA3tHS_egV4R_BtQ3a priority: 102 providerName: Directory of Open Access Journals |
Title | Redefined clinical spectra of diabetic foot syndrome |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30425505 https://search.proquest.com/docview/2133431952 https://pubmed.ncbi.nlm.nih.gov/PMC6201996 https://doaj.org/article/75ea40d3e24a48b9abdae8eabe0d4c3b |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_aDsZexr6Xrcs82NiTE9v6sh7b0hIGKSVbR96EPrvAapcs_f93ku1Qs7e9CesMvtOd7k7-3Qngs9WElYSHPGIXc_R4JtfEU7QrG6jUIXb8jmiLS764pt_WbH0AbKiFSaB9azaz5vftrNn8StjKu1s7H3Bi86vlGUevhXH6_BAOUUGHFL3bfhmv053HZSl4zgmlHdo9Xscz_7lYLWffSy5ZEW-xiZl8DNBHLil17v93f37goMbgyQfe6OIZPO3DyOyk-9zncOCbF_B42f8ofwl05Z0POHTZUPuYpaLKrc7akHUnrhubhbbdZUPXgldwfXH-42yR9xck5BYTjV0etKaOOGp9LQXGeT5UWlclZzIQI1zhq9JSbQQLhZeOGOOC4NZYVhXCE-vIazhq2sa_hUyUVhYsOMYpZiRB1oJQpr2XNIhSGjmBL4OM1F3XB0Nh_hDFqqJYVS_WCZxGAe5pYvfq9KDd3qh-DZVgXtPCEV9RTWsjtXHa1x45L5AZYibwMYpfdaWgextUJwzz2Qisw8_5miiiFaLkrO6LCZCZ2M9qRHk8okTrsaPpT8MSqzgVIWeNb-__IGuEYHQlGfL0plvyPVeD5kxAjJRhxPZ4BnU5Ne_udffdf7_5Hp7goO6OgY7haLe99x8wMNqZKZrDWkzh0en55dVqmo4Xpsk4_gIMaQ-E |
link.rule.ids | 230,315,730,783,787,867,888,2109,27938,27939,31734,33759,53806,53808 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgEX3oWFQoME4pRssn7Fx1JRLdCtUGmr3iw_YQVNqiV74dczzmPVwAluUexI-TwzmRnnmzHAa6sJKwgPaeQupujxTKqJp2hXNlCpQ-z4HdkWx3x-Rj9esIstYEMtTEvat2aZVT8us2r5reVWXl3a6cATm35eHHD0WhinT2_ATbTXnA9JevcBZrxsTz0uCsFTTijt-O7xQJ7p-fxkkX0puGR5PMcm5vIxRB85pbZ3_99f6GsuakyfvOaPDu_B-YCko6F8z9aNyeyvP5o8_jPU-3C3j1CT_W74AWz56iHcWvT_4B8BPfHOB7x0yVBWmbT1miud1CHpNnOXNgl13SRDQ4THcHb4_vRgnvZnL6QWc5gmDVpTRxy1vpQCQ0gfZlrPCs5kIEa43M8KS7URLOReOmKMC4JbY9ksF55YR3Zgu6or_xQSUViZs-AYp5jsBFkKQpn2XtIgCmnkBN4Mi6-uuhYbClOTKC8V5aV6eU3gXZTMZk5sjN3eqFdfVb9mSjCvae6In1FNSyO1cdqXHpHnCIaYCexFuaquynRj3mqfYaocOXv4Om_bGdHAceWs7usUEExslTWauTuaiYZpR8OvBt1RcSiy2Spfr38iNEIwcJMMMT3pdGmDalDJCYiRlo1gj0dQd9q-4L2uPPvvJ_fg9vx0caSOPhx_eg538GbZ7TbtwnazWvsXGH815mVrbb8BHz8uBw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BkSou5U0DLTUSiJOf-_Ie20IUHqmqQlHFZbVPiKB2FJwLv55ZP6IYbr1Z3rHkzzPjmbG_nUHolVGY5pj5OHAXY4h4OlbYEfAr44lQPnT8DmyLMza7JB-u6NXWqK-WtG_0Iql-XSfV4kfLrVxem3TgiaXn81MGUQvy9HRpfXob3QGfzcqhUO9ewpSV7eTjPOcsZpiQjvMehvKkX2cX8-RzzgTNwiybUM-HNH0UmNr-_f-_pbfC1JhCuRWTpvfQtwFNR0X5mawbnZg__zR6vBHc-2ivz1Sj407kAbrlqodod97_i3-EyIWzzsOhjYbtlVG7b3OlotpH3UfdhYl8XTfR0BjhMbqcvvtyOov7GQyxgVqmib1SxGJLjCsFh1TS-UKpImdUeKy5zVyRG6I0pz5zwmKtrefMaEOLjDtsLH6Cdqq6cvso4rkRGfWWMgJFjxclx4Qq5wTxPBdaTNDrQQFy2bXakFCiBJ3JoDPZ62yCToJ2NjKhQXZ7ol59l_1zk5w6RTKLXUEUKbVQ2ipXOkCeARisJ-go6FZ2u003bi6PKZTMgbsHt_OmlQiODk_OqH6_AoAJLbNGkgcjSXBQM1p-OdiPDEuB1Va5ev0boGEMCZyggOlpZ08bVINZThAfWdoI9ngF7KftD97by7MbX3mEds_fTuWn92cfn6O7cK7sPjodoJ1mtXaHkIY1-kXrcH8Bjnwwhw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Redefined+clinical+spectra+of+diabetic+foot+syndrome&rft.jtitle=Vascular+health+and+risk+management&rft.au=Shatnawi%2C+Nawaf+J&rft.au=Al-Zoubi%2C+Nabil+A&rft.au=Hawamdeh%2C+Hasan&rft.au=Khader%2C+Yousef+S&rft.date=2018-01-01&rft.pub=Dove+Medical+Press+Limited&rft.issn=1178-2048&rft.eissn=1178-2048&rft.volume=14&rft.spage=291&rft_id=info:doi/10.2147%2FVHRM.S169502&rft.externalDocID=A582508559 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-2048&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-2048&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-2048&client=summon |